First Time Loading...
Z

Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267

Watchlist Manager
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Watchlist
Price: 8.33 CNY 2.08% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

Price Targets Summary
Zhejiang Hisun Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Hisun Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.

Lowest
Price Target
7.47 CNY
10% Downside
Average
Price Target
7.55 CNY
9% Downside
Highest
Price Target
7.77 CNY
7% Downside
Zhejiang Hisun Pharmaceutical Co Ltd Competitors:
Price Targets
CAPLIPOINT
Caplin Point Laboratories Ltd
24% Upside
688356
Jenkem Technology Co Ltd
33% Upside
WVE
WAVE Life Sciences Ltd
116% Upside
KOPRAN
Kopran Ltd
70% Downside
001630
Chongkundang Holdings Corp
15% Upside
KDEV
Karolinska Development AB
187% Upside
300436
Fujian Cosunter Pharmaceutical Co Ltd
274% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
2% Downside

Revenue
Forecast

Revenue Estimate
Zhejiang Hisun Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's revenue is 2%. The projected CAGR for the next 3 years is 5%.

2%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhejiang Hisun Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 7%.

4%
Past Growth
7%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
Zhejiang Hisun Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 1%.

6%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Hisun Pharmaceutical Co Ltd's stock price target?
Price Target
7.55 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's revenue is 2%. The projected CAGR for the next 3 years is 5%.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 7%.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 1%.